Production of foot-and-mouth disease virus capsid proteins by the TEV protease

Puckette, Michael; Smith, Justin D.; Gabbert, Lindsay; Schutta, Christopher; Barrera, José; Clark, Benjamin A.; Neilan, John G.; Rasmussen, Max

doi:10.1016/j.jbiotec.2018.03.012

Title: Production of foot-and-mouth disease virus capsid proteins by the TEV protease

Full Record
Other Related Research

Authors:: Puckette, Michael; Smith, Justin D.; Gabbert, Lindsay; Schutta, Christopher; Barrera, José; Clark, Benjamin A.; Neilan, John G.; Rasmussen, Max

Publication Date:: Fri Jun 01 00:00:00 EDT 2018

Sponsoring Org.:: USDOE

OSTI Identifier:: 1434552

Grant/Contract Number:: AC05-06OR23100

Resource Type:: Published Article

Journal Name:: Journal of Biotechnology

Additional Journal Information:: Journal Name: Journal of Biotechnology Journal Volume: 275 Journal Issue: C; Journal ID: ISSN 0168-1656

Publisher:: Elsevier

Country of Publication:: Netherlands

Language:: English

Citation Formats


                    Puckette, Michael, Smith, Justin D., Gabbert, Lindsay, Schutta, Christopher, Barrera, José, Clark, Benjamin A., Neilan, John G., and Rasmussen, Max. Production of foot-and-mouth disease virus capsid proteins by the TEV protease.  Netherlands: N. p., 2018. 
Web.  doi:10.1016/j.jbiotec.2018.03.012.

Copy to clipboard


                    Puckette, Michael, Smith, Justin D., Gabbert, Lindsay, Schutta, Christopher, Barrera, José, Clark, Benjamin A., Neilan, John G., & Rasmussen, Max. Production of foot-and-mouth disease virus capsid proteins by the TEV protease.  Netherlands.  https://doi.org/10.1016/j.jbiotec.2018.03.012

Copy to clipboard


                    Puckette, Michael, Smith, Justin D., Gabbert, Lindsay, Schutta, Christopher, Barrera, José, Clark, Benjamin A., Neilan, John G., and Rasmussen, Max. Fri .  
"Production of foot-and-mouth disease virus capsid proteins by the TEV protease".  Netherlands.  https://doi.org/10.1016/j.jbiotec.2018.03.012.

Copy to clipboard


                    
@article{osti_1434552,

  title        = {Production of foot-and-mouth disease virus capsid proteins by the TEV protease},

  author       = {Puckette, Michael and Smith, Justin D. and Gabbert, Lindsay and Schutta, Christopher and Barrera, José and Clark, Benjamin A. and Neilan, John G. and Rasmussen, Max},

  abstractNote = {},

  doi          = {10.1016/j.jbiotec.2018.03.012},

  journal      = {Journal of Biotechnology},

  number       = C,

  volume       = 275,

  place        = {Netherlands},

  year         = {Fri Jun 01 00:00:00 EDT 2018},

  month        = {Fri Jun 01 00:00:00 EDT 2018}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
https://doi.org/10.1016/j.jbiotec.2018.03.012

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 4 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Effect of foot-and-mouth disease virus 3C protease B₂ β-strand proline mutagenesis on expression and processing of the P1 polypeptide using a plasmid expression vector

Journal Article Martel, Erica ; Forzono, Emily ; Kurker, Richard ; ... - Journal of General Virology

The production of experimental molecular vaccines against foot-and-mouth disease virus utilizes the viral encoded 3C protease for processing of the P1 polyprotein. Expression of wild type 3C protease is detrimental to host cells. The molecular vaccine constructs containing the 3C protease L127P mutant significantly reduce adverse effects associated with protease expression while retaining the ability to process and assemble virus-like particles. In published 3C protease crystal structures, the L127 residue is contained within the B₂ β-strand as part of the A₂–B₂ β-sheet. To provide insight into the mechanism by which the L127P mutant alters the properties of the 3C protease,more »« less
Cited by 3
https://doi.org/10.1099/jgv.0.001204

Full Text Available
Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development

Journal Article Puckette, Michael ; Clark, Benjamin A. ; Smith, Justin D. ; ... - Journal of Virology

The foot-and-mouth disease virus (FMDV) afflicts livestock in more than 80 countries, limiting food production and global trade. Production of foot-and-mouth disease (FMD) vaccines requires cytosolic expression of the FMDV 3C protease to cleave the P1 polyprotein into mature capsid proteins, but the FMDV 3C protease is toxic to host cells. To identify less-toxic isoforms of the FMDV 3C protease, we screened 3C mutants for increased transgene output in comparison to wild-type 3C using aGaussialuciferase reporter system. The novel point mutation 3C(L127P) increased yields of recombinant FMDV subunit proteins in mammalian and bacterial cells expressing P1-3C transgenes and retained themore »« less
Cited by 19
https://doi.org/10.1128/jvi.00924-17

Full Text Available
Effect of Foot-and-Mouth Disease Virus 2B Viroporin on Expression and Extraction of Mammalian Cell Culture Produced Foot-and-Mouth Disease Virus-like Particles

Journal Article Primavera, Victoria ; Simmons, Janine ; Clark, Benjamin A. ; ... - Vaccines

To improve the production of foot-and-mouth disease (FMD) molecular vaccines, we sought to understand the effects of the FMD virus (FMDV) 2B viroporin in an experimental, plasmid-based, virus-like particle (VLP) vaccine. Inclusion of the FMDV viroporin 2B into the human Adenovirus 5 vectored FMD vaccine enhanced transgene expression despite independent 2B expression negatively affecting cell viability. Evaluating both wildtype 2B and mutants with disrupted viroporin activity, we confirmed that viroporin activity is detrimental to overall transgene expression when expressed independently. However, the incorporation of 2B into an FMD molecular vaccine construct containing a wildtype FMDV 3C protease, a viral encodedmore »« less
https://doi.org/10.3390/vaccines10091506
Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine

Journal Article Barrera, José ; Brake, David A. ; Schutta, Christopher ; ... - Vaccine

We investigated the serotype- and topotype versatility of a replication-deficient human adenovirus serotype 5 vectored foot-and-mouth disease (FMD) vaccine platform (AdtFMD). Sixteen AdtFMD recombinant subunit monovalent vaccines targeting twelve distinct FMD virus (FMDV) serotype/topotypes in FMD Regional Pools I-VII were constructed. The AdtA24 serotype conditionally licensed vaccine served as the basis for vaccine design and target dose for cattle clinical trials. Several vaccines contained an additional RGD motif genetic insertion in the adenovector fiber knob, and/or a full-length 2B gene insertion in the FMDV P1 gene cassette. In 13 of the 22 efficacy studies conducted, naïve control and AdtFMD vaccinatedmore »« less
Cited by 6
https://doi.org/10.1016/j.vaccine.2018.10.031

Full Text Available
Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model

Journal Article Neilan, John G. ; Schutta, Christopher ; Barrera, José ; ... - BMC Veterinary Research

A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized with a replication-deficient human adenovirus-vectored FMDV A24/Cruzeiro/BRA/55 capsid-based subunit vaccine (AdtA24). In two independent vaccine efficacy trials, AdtA24 was administered once intramuscularly in the neck 7 days prior to contact with FMDV A24/Cruzeiro/BRA/55-infected seeder steers.
Cited by 6
https://doi.org/10.1186/s12917-018-1582-1

Similar Records